Answers are grounded in this paper and cite their sources.
Chronic treatment of rats with the neuroleptic drugs haloperidol, fluphenazine, and reserpine elicits a 20 to 25% increase in striatal dopamine receptor binding assayed with [3H]haloperidol. This increase in receptor sites may account for behavioral supersensitivity to dopamine receptor stimulants in such animals and for tardive dyskinesia in patients treated with these drugs.
No takes yet. Share an insight, caveat, or question.
Burt et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: